Meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic. The effectiveness of meprobamate tablets in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.
DOSAGE AND ADMINISTRATION
Meprobamate Tablets USP: The usual adult daily dosage is 1200 mg to 1600 mg, in three or four divided doses; a daily dosage above 2400 mg is not recommended. The usual daily dosage for children ages six to twelve years is 200 mg to 600 mg, in two or three divided doses.
Not recommended for children under age 6 (see Usage in Children).
Meprobamate Tablets USP 200 mg are scored, round, white tablets imprinted 591-B supplied in bottles of 100 and 1000.
Meprobamate Tablets USP 400 mg are scored, round, white tablets imprinted 591-A supplied in bottles of 100 and 1000.
Dispense in well-closed container with child-resistant closure.
Store at controlled room temperature: 15°-30°C (59°-86°F). [See USP.]
Watson Laboratories, Inc. Corona, CA 92880, USA. Revised: April 2004. FDA Rev date: 4/25/2001
Last reviewed on RxList: 11/7/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Meprobamate Information
Meprobamate - User Reviews
Meprobamate User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get tips on therapy and treatment.